Samhita Chaudhuri

Samhita Chaudhuri

Auto-generated profile, based on publicly available information

Samhita Chaudhuri

Department of Physiology and Cell Biology, The Ohio State University College of Medicine, Columbus, OH, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
NSNuo Sun
Nuo Sun
HBHayley Barta
Hayley Barta
SCSamhita Chaudhuri
Samhita Chaudhuri
KCKangxuan Chen
Kangxuan Chen
JJJiacheng Jin
Jiacheng Jin
TFToren Finkel
Toren Finkel
The healthy heart relies on mitochondrial fatty acid β-oxidation (FAO) to sustain its high energy demands. FAO deficiencies can cause muscle weakness, cardiomyopathy, and, in severe cases, neonatal/infantile mortality. Although FAO deficits are thought to induce mitochondrial stress and activate mitophagy, a quality control mechanism that eliminates damaged mitochondria, the mechanistic link in the heart remains unclear. Here we show that mitophagy is unexpectedly suppressed in FAO-deficient hearts despite pronounced mitochondrial stress, using a cardiomyocyte-specific carnitine palmitoyltransferase 2 (CPT2) knockout model. Multi-omics profiling reveals impaired PINK1/Parkin signaling and dysregulation of PARL, a mitochondrial protease essential for PINK1 processing. Strikingly, deletion of USP30, a mitochondrial deubiquitinase that antagonizes PINK1/Parkin function, restores mitophagy, improves cardiac function, and significantly extends survival in FAO-deficient animals. These findings redefine the mitophagy response in FAO-deficient hearts and establish USP30 as a promising therapeutic target for metabolic cardiomyopathies and broader heart failure characterized by impaired FAO.

15 August 2025 in Science Advances
Verified
Journal Article
Open access
RZRuohan Zhang
Ruohan Zhang
FGFengxia Gao
Fengxia Gao
JLJianying Li
Jianying Li
JJJiacheng Jin
Jiacheng Jin
KCKangxuan Chen
Kangxuan Chen
NSNuo Sun
Nuo Sun
The exhaustion of tumor-infiltrating CD8 + T cells poses a substantial challenge in cancer immunotherapy, with mitochondrial health essential for sustaining T cell functionality. Mitophagy, a critical process for mitochondrial quality control, is severely impaired in exhausted CD8 + T cells, yet the underlying mechanisms remain unclear. We identified ubiquitin-specific protease 30 (USP30), a mitochondrial deubiquitinase that inhibits mitophagy, as a key factor up-regulated in exhausted CD8 + T cells. Notably, prolonged antigen stimulation triggers the T cell receptor and nuclear factor of activated T cell 1 signaling, which drives the transcriptional up-regulation of USP30. Excitingly, our interventions targeting USP30 through genetic deletion or pharmacological inhibition effectively restored mitophagy, improved mitochondrial fitness, and rejuvenated CD8 + T cell effector functions. These interventions reinvigorated antitumor responses and markedly suppressed tumor growth. Our findings establish USP30 as a critical regulator of mitophagy and a promising therapeutic target for reversing T cell exhaustion and enhancing the efficacy of cancer immunotherapy.

16 June 2022 in Gastroenterology
Verified
Journal Article
Closed access
EVEgina C. Villalobos-Hernandez
Egina C. Villalobos-Hernandez
FOFernando Ochoa-Cortes
Fernando Ochoa-Cortes
EMElvio Mazzotta
Elvio Mazzotta
SCSamhita Chaudhuri
Samhita Chaudhuri
SSSuren Soghomonyan
Suren Soghomonyan
FCFievos L. Christofi
Fievos L. Christofi